Literature DB >> 15918185

Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.

Shu-Hui Zhang1, Wen-Ming Cong, Zhi-Hong Xian, Meng-Chao Wu.   

Abstract

AIM: To determine the features of microsatellite alterations and their association with clinicopathological characteristics of hepatocellular carcinoma (HCC).
METHODS: Loss of heterozygosity (LOH) and microsatellite instability (MSI) of 55 microsatellite loci were detected with PCR-based microsatellite polymorphism analyses in tumors and corresponding noncancerous liver tissues of 56 surgically resected HCCs using the MegaBACE 500 automatic DNA analysis system.
RESULTS: LOH was found in 44 of 56 HCCs (78.6%) at one or several loci. Frequencies of LOH on 1p, 4q, 8p, 16q, and 17p were 69.6% (39/56), 71.4% (40/56), 66.1% (37/56), 66.1% (37/56), and 64.3% (36/56), respectively. MSI was found in 18 of 56 HCCs (32.1%) at one or several loci. Ten of fifty-six (17.9%) HCCs had MSI-H. Serum HBV infection, alpha-fetoprotein concentration, tumor size, cirrhosis, histological grade, tumor capsule, as well as tumor intrahepatic metastasis, might be correlated with LOH on certain chromosome regions.
CONCLUSION: Frequent microsatellite alterations exist in HCC. LOH, which represents a tumor suppressor gene pathway, plays a more important role in hepatocarcinogenesis. MSI, which represents a mismatch repair gene pathway, is a rare event during liver carcinogenesis. Furthermore, LOH on certain chromosome regions may be correlated with clinicopathological characteristics in HCC.

Entities:  

Mesh:

Year:  2005        PMID: 15918185      PMCID: PMC4305835          DOI: 10.3748/wjg.v11.i20.3034

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

Review 1.  Genetics of hepatocellular carcinoma.

Authors:  M A Buendia
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

2.  Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction.

Authors:  K D Berg; C L Glaser; R E Thompson; S R Hamilton; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

3.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

4.  The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.

Authors:  L X Qin; Z Y Tang; J S Sham; Z C Ma; S L Ye; X D Zhou; Z Q Wu; J M Trent; X Y Guan
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

5.  Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China.

Authors:  S A Becker; Y Z Zhou; B L Slagle
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

6.  Genomic aberrations in human hepatocellular carcinomas of differing etiologies.

Authors:  N Wong; P Lai; E Pang; L F Fung; Z Sheng; V Wong; W Wang; Y Hayashi; E Perlman; S Yuna; J W Lau; P J Johnson
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

7.  Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas.

Authors:  Won Sang Park; Jong Heun Lee; Jik Young Park; Seong Whan Jeong; Min Sun Shin; Hong Sug Kim; Sang Kyu Lee; Shi Nae Lee; Sug Hyung Lee; Chul Geun Park; Nam Jin Yoo; Jung Young Lee
Journal:  Cancer Lett       Date:  2002-04-25       Impact factor: 8.679

8.  Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma.

Authors:  C Liao; M Zhao; H Song; K Uchida; K K Yokoyama; T Li
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

9.  Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.

Authors:  Y Yumoto; T Hanafusa; H Hada; T Morita; S Ooguchi; N Shinji; T Mitani; K Hamaya; N Koide; T Tsuji
Journal:  J Gastroenterol Hepatol       Date:  1995 Mar-Apr       Impact factor: 4.029

Review 10.  Multiple mutations and cancer.

Authors:  Lawrence A Loeb; Keith R Loeb; Jon P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  14 in total

1.  Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.

Authors:  Xiaoying Zhang; Hiu Ming Li; Zhiyan Liu; Gengyin Zhou; Qinghui Zhang; Tingguo Zhang; Jianping Zhang; Cuijuan Zhang
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

2.  Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.

Authors:  Jie Ding; Shenglin Huang; Shunquan Wu; Yingjun Zhao; Linhui Liang; Mingxia Yan; Chao Ge; Jian Yao; Taoyang Chen; Dafang Wan; Hongyang Wang; Jianren Gu; Ming Yao; Jinjun Li; Hong Tu; Xianghuo He
Journal:  Nat Cell Biol       Date:  2010-03-21       Impact factor: 28.824

Review 3.  Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristics.

Authors:  Yoshihiko Yano; Takeshi Azuma; Yoshitake Hayashi
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

5.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

6.  Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma.

Authors:  Claire Goumard; Christele Desbois-Mouthon; Dominique Wendum; Claire Calmel; Fatiha Merabtene; Olivier Scatton; Françoise Praz
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

7.  Role of E-cadherin gene in gall bladder cancer and its precursor lesions.

Authors:  T Padma Priya; V K Kapoor; N Krishnani; Vinita Agrawal; Suraksha Agrawal
Journal:  Virchows Arch       Date:  2010-04-08       Impact factor: 4.064

8.  Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.

Authors:  Michele Barone; Daniela Spano; Maria D'Apolito; Marta Centra; Carla Lasalandra; Mario Capasso; Alfredo Di Leo; Stefano Volinia; Diego Arcelli; Natalia Rosso; Antonio Francavilla; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

9.  LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma.

Authors:  Guo-Liang Huang; Bin-Kui Li; Mei-Yin Zhang; Hui-Zhong Zhang; Rong-Rong Wei; Yun-Fei Yuan; Ming Shi; Xiao-Qian Chen; Long Huang; An-Hua Li; Bi-Jun Huang; Hong-Hua Li; Hui-Yun Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

10.  Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.

Authors:  Yi-Ran Cai; Li Gong; Xiao-Ying Teng; Hong-Tu Zhang; Cheng-Feng Wang; Guo-Lian Wei; Lei Guo; Fang Ding; Zhi-Hua Liu; Qin-Jing Pan; Qin Su
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.